Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1267109.RABU57-qi596Yql7zjfgeq0bD-sTGhEmmBrww5YtmI4bw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1267109.RABU57-qi596Yql7zjfgeq0bD-sTGhEmmBrww5YtmI4bw130_assertion type Assertion NP1267109.RABU57-qi596Yql7zjfgeq0bD-sTGhEmmBrww5YtmI4bw130_head.
- NP1267109.RABU57-qi596Yql7zjfgeq0bD-sTGhEmmBrww5YtmI4bw130_assertion description "[The therapeutic project has to consider tyrosine kinase inhibitors in the case of nonsmall cell lung cancer with active epidermal growth factor receptor mutations or anaplastic lymphoma kinase rearrangement.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267109.RABU57-qi596Yql7zjfgeq0bD-sTGhEmmBrww5YtmI4bw130_provenance.
- NP1267109.RABU57-qi596Yql7zjfgeq0bD-sTGhEmmBrww5YtmI4bw130_assertion evidence source_evidence_literature NP1267109.RABU57-qi596Yql7zjfgeq0bD-sTGhEmmBrww5YtmI4bw130_provenance.
- NP1267109.RABU57-qi596Yql7zjfgeq0bD-sTGhEmmBrww5YtmI4bw130_assertion SIO_000772 25726551 NP1267109.RABU57-qi596Yql7zjfgeq0bD-sTGhEmmBrww5YtmI4bw130_provenance.
- NP1267109.RABU57-qi596Yql7zjfgeq0bD-sTGhEmmBrww5YtmI4bw130_assertion wasDerivedFrom befree-2016 NP1267109.RABU57-qi596Yql7zjfgeq0bD-sTGhEmmBrww5YtmI4bw130_provenance.
- NP1267109.RABU57-qi596Yql7zjfgeq0bD-sTGhEmmBrww5YtmI4bw130_assertion wasGeneratedBy ECO_0000203 NP1267109.RABU57-qi596Yql7zjfgeq0bD-sTGhEmmBrww5YtmI4bw130_provenance.